miR-590-3p 过度表达可提高 hiPSC-CMs 修复心肌的疗效

IF 8.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Zhiwei Zhang MD , Xiaoting Li MD , Jiawei Zhuang MD , Qingwei Ding MD , Hui Zheng MD , Teng Ma MD , Qingyou Meng MD , Ling Gao PhD
{"title":"miR-590-3p 过度表达可提高 hiPSC-CMs 修复心肌的疗效","authors":"Zhiwei Zhang MD ,&nbsp;Xiaoting Li MD ,&nbsp;Jiawei Zhuang MD ,&nbsp;Qingwei Ding MD ,&nbsp;Hui Zheng MD ,&nbsp;Teng Ma MD ,&nbsp;Qingyou Meng MD ,&nbsp;Ling Gao PhD","doi":"10.1016/j.jacbts.2023.11.005","DOIUrl":null,"url":null,"abstract":"<div><p>Recent evidence demonstrates that low engraftment rates limit the efficacy of human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) for cardiac repair after myocardial infarction. In this study, we attempted to overcome this limitation by enhancing the proliferative capacity of transplanted hiPSC-CMs. We found that miR-590-3p overexpression increased the proliferative capacity of hiPSC-CMs. miR-590-3p overexpression increased the number of engrafted cells and had a higher efficacy for myocardial repair than control cells. Moreover, we confirmed the safety of using miR-590-3p-overexpressing hiPSC-CMs in pig hearts. These results indicated that miR-590-3p overexpression stimulated hiPSC-CM cell cycle re-entry to induce cell proliferation and increased the therapeutic efficacy in MI.</p></div>","PeriodicalId":14831,"journal":{"name":"JACC: Basic to Translational Science","volume":"9 5","pages":"Pages 557-573"},"PeriodicalIF":8.4000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452302X23005193/pdfft?md5=06e86e28db0c5b4549397c70e494adf9&pid=1-s2.0-S2452302X23005193-main.pdf","citationCount":"0","resultStr":"{\"title\":\"miR-590-3p Overexpression Improves the Efficacy of hiPSC-CMs for Myocardial Repair\",\"authors\":\"Zhiwei Zhang MD ,&nbsp;Xiaoting Li MD ,&nbsp;Jiawei Zhuang MD ,&nbsp;Qingwei Ding MD ,&nbsp;Hui Zheng MD ,&nbsp;Teng Ma MD ,&nbsp;Qingyou Meng MD ,&nbsp;Ling Gao PhD\",\"doi\":\"10.1016/j.jacbts.2023.11.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Recent evidence demonstrates that low engraftment rates limit the efficacy of human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) for cardiac repair after myocardial infarction. In this study, we attempted to overcome this limitation by enhancing the proliferative capacity of transplanted hiPSC-CMs. We found that miR-590-3p overexpression increased the proliferative capacity of hiPSC-CMs. miR-590-3p overexpression increased the number of engrafted cells and had a higher efficacy for myocardial repair than control cells. Moreover, we confirmed the safety of using miR-590-3p-overexpressing hiPSC-CMs in pig hearts. These results indicated that miR-590-3p overexpression stimulated hiPSC-CM cell cycle re-entry to induce cell proliferation and increased the therapeutic efficacy in MI.</p></div>\",\"PeriodicalId\":14831,\"journal\":{\"name\":\"JACC: Basic to Translational Science\",\"volume\":\"9 5\",\"pages\":\"Pages 557-573\"},\"PeriodicalIF\":8.4000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2452302X23005193/pdfft?md5=06e86e28db0c5b4549397c70e494adf9&pid=1-s2.0-S2452302X23005193-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC: Basic to Translational Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2452302X23005193\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC: Basic to Translational Science","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452302X23005193","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

最近的证据表明,低移植率限制了人类诱导多能干细胞衍生的心肌细胞(hiPSC-CMs)在心肌梗死后进行心脏修复的功效。在本研究中,我们试图通过增强移植的hiPSC-CMs的增殖能力来克服这一限制。我们发现,miR-590-3p 的过表达提高了 hiPSC-CMs 的增殖能力,与对照细胞相比,miR-590-3p 的过表达增加了移植细胞的数量,并具有更高的心肌修复功效。此外,我们还证实了在猪心肌中使用过表达 miR-590-3p 的 hiPSC-CMs 是安全的。这些结果表明,miR-590-3p过表达能刺激hiPSC-CM细胞周期重入,诱导细胞增殖,提高对心肌梗死的疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
miR-590-3p Overexpression Improves the Efficacy of hiPSC-CMs for Myocardial Repair

Recent evidence demonstrates that low engraftment rates limit the efficacy of human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) for cardiac repair after myocardial infarction. In this study, we attempted to overcome this limitation by enhancing the proliferative capacity of transplanted hiPSC-CMs. We found that miR-590-3p overexpression increased the proliferative capacity of hiPSC-CMs. miR-590-3p overexpression increased the number of engrafted cells and had a higher efficacy for myocardial repair than control cells. Moreover, we confirmed the safety of using miR-590-3p-overexpressing hiPSC-CMs in pig hearts. These results indicated that miR-590-3p overexpression stimulated hiPSC-CM cell cycle re-entry to induce cell proliferation and increased the therapeutic efficacy in MI.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
JACC: Basic to Translational Science
JACC: Basic to Translational Science CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
14.20
自引率
1.00%
发文量
161
审稿时长
16 weeks
期刊介绍: JACC: Basic to Translational Science is an open access journal that is part of the renowned Journal of the American College of Cardiology (JACC). It focuses on advancing the field of Translational Cardiovascular Medicine and aims to accelerate the translation of new scientific discoveries into therapies that improve outcomes for patients with or at risk for Cardiovascular Disease. The journal covers thematic areas such as pre-clinical research, clinical trials, personalized medicine, novel drugs, devices, and biologics, proteomics, genomics, and metabolomics, as well as early phase clinical trial methodology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信